Abbvie Inc. $7,017,222 Acelyrin, Inc. $209,000 Neumora Therapeutics, Inc. $4,521,734 Abbvie Inc. $7,017,222 Acelyrin, Inc. $209,000 Neumora Therapeutics, Inc. $4,521,734